These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33732633)

  • 21. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Xu L; Li Z; Su Z; Yang Y; Ma G; Yu R; Zhang S
    Vaccine; 2019 Feb; 37(7):956-964. PubMed ID: 30655174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBV core particles as a carrier for B cell/T cell epitopes.
    Pumpens P; Grens E
    Intervirology; 2001; 44(2-3):98-114. PubMed ID: 11509871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
    Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
    Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.
    Masavuli MG; Wijesundara DK; Torresi J; Gowans EJ; Grubor-Bauk B
    Front Microbiol; 2017; 8():2413. PubMed ID: 29259601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Ramirez A; Morris S; Maucourant S; D'Ascanio I; Crescente V; Lu IN; Farinelle S; Muller CP; Whelan M; Rosenberg W
    Vaccine; 2018 Feb; 36(6):873-880. PubMed ID: 29306508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
    Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
    Chen S; Zheng D; Li C; Zhang W; Xu W; Liu X; Fang F; Chen Z
    Biomed Res Int; 2015; 2015():901817. PubMed ID: 25767809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
    Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
    Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental and molecular dynamics simulation studies on the physical properties of three HBc-VLP derivatives as nanoparticle protein vaccine candidates.
    Luo H; Ma Y; Bi J; Li Z; Wang Y; Su Z; Gerstweiler L; Ren Y; Zhang S
    Vaccine; 2024 May; ():. PubMed ID: 38811268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold.
    Swanson J; Fragkoudis R; Hawes PC; Newman J; Burman A; Panjwani A; Stonehouse NJ; Tuthill TJ
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33920339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.